NCT00180102View on ClinicalTrials.gov

AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years

PHASE4CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Leukemia, Nonlymphocytic, Acute
Interventions
DRUG

Cytarabine vs. Cytarabine+Amsacrine+Mitoxantrone

PROCEDURE

early allogeneic PBSCT within induction therapy

PROCEDURE

autologous PBSCT

Trial Locations (1)

01307

Medical Department I, University Hospital Carl Gustav Carus, Dresden

All Listed Sponsors
lead

Technische Universität Dresden

OTHER

NCT00180102 - AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years | Biotech Hunter | Biotech Hunter